STUDIES ON THE BIOCHEMICAL BASIS OF DISTAL AXONOPATHIES–I. INHIBITION OF GLYCOLYSIS BY NEUROTOXIC HEXACARBON COMPOUNDS

M. I. Sabri, C. L. Moore, P. S. Spencer

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Abstract

Abstract— Neurotoxic hexacarbon compounds 2,5‐hexanedione (2,5‐HD) and methyl n‐butyl ketone (MnBK) inhibit crystalline and endogenous CNS and PNS glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH). Preincubation of the enzyme with the toxin was necessary for inhibition. The enzyme activity of GAPDH was preserved by the addition of dithiothreitol in the presence of either neurotoxin. By contrast, lactate dehydrogenase (LDH) activity was not inhibited by these neurotoxic chemicals. Neurologically inactive compounds 1,6‐hexanediol and acetone failed to inhibit GAPDH. The present data indicate that 2,5‐HD and M “BK block energy metabolism by inhibiting glycolysis at the site of GAPDH. These observations may account for the known failure of GAPDH‐dependent axonal transport and the axonal degeneration which occurs in hexacarbon neuropathy.

Original languageEnglish (US)
Pages (from-to)683-689
Number of pages7
JournalJournal of neurochemistry
Volume32
Issue number3
DOIs
StatePublished - Mar 1979
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'STUDIES ON THE BIOCHEMICAL BASIS OF DISTAL AXONOPATHIES–I. INHIBITION OF GLYCOLYSIS BY NEUROTOXIC HEXACARBON COMPOUNDS'. Together they form a unique fingerprint.

Cite this